Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.
Cotiviti, a leader in data-driven healthcare solutions, announces an agreement to acquire Edifecs, a pioneer in healthcare ...
Cotiviti, a healthcare data company backed by KKR, is reportedly on the brink of finalizing a deal to acquire its smaller ...
$540 $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025. Then $75 per month. Complete digital access to ...
The firm said it would increase its investment in the companies by $1.1 billion in total as part of its unusual strategy of ...
The floodgates may not have fully opened for private equity deals in 2024, but KKR’s capital markets team led landmark financings for portfolio firms CyrusOne and Cotiviti and a string of ECM and ...
Citi analyst Christopher Allen reiterated a Buy rating on KKR & Co (KKR – Research Report) today. The company’s shares closed yesterday at ...
Company's fee-related earnings also miss expectations Stock down 8.5% KKR set to increase ownership in three existing private equity investments Feb 4 (Reuters) - KKR & Co's (KKR.N), opens new tab ...
In a report released today, Michael Cyprys from Morgan Stanley maintained a Hold rating on KKR & Co (KKR – Research Report), with a price target of $156.00. The company’s shares closed ...
TOKYO (Reuters) -U.S. private equity firm KKR has sweetened its offer for Japan's Fuji Soft by 4%, the latest salvo in its protracted and messy bidding war with Bain Capital for the $4 billion IT ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results